<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00551343</url>
  </required_header>
  <id_info>
    <org_study_id>H07/045</org_study_id>
    <secondary_id>X07-0178</secondary_id>
    <nct_id>NCT00551343</nct_id>
  </id_info>
  <brief_title>Gut Derived Hormones, Body Composition and Metabolism in Prader-Willi Syndrome</brief_title>
  <official_title>Contribution of a GLP-1 Agonist to Appetite Regulation, Metabolism and Body Composition in Subjects With Prader-Willi Syndrome.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Garvan Institute of Medical Research</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Garvan Institute of Medical Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the effects of a GLP-1 agonist on satiety
      hormones in patients with Prader-Willi Syndrome (genetic defect causing obesity).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prader-Willi Syndrome (PWS) is the most frequent known genetic disorder of obesity.
      Hyperphagia is the main barrier to independent living in adults with PWS, and hitherto
      behavioural restraints and environmental modification are the only effective management
      measure. The emerging costs for professional care are immense. Thus, there is an urgent need
      for treatment which reduce appetite and food intake in this patient group. Agonists of the
      gut derived hormone GLP-1 which reduces food intake and causes weight loss due to slowed
      gastric emptying and through direct central effects. The aim of this pilot drug trial is to
      analyse the effect of a GLP-1 agonist on appetite regulating hormones, insulin secretion and
      energy expenditure before and after a meal.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2007</start_date>
  <completion_date type="Anticipated">September 2008</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>satiety hormones</measure>
    <time_frame>1 day</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>appetite (visual analogue scale) insulin secretion</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Prader-Willi Syndrome</condition>
  <arm_group>
    <arm_group_label>PWS</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Exenatide</intervention_name>
    <description>10ug Exenatide single s.c. injection</description>
    <arm_group_label>PWS</arm_group_label>
    <arm_group_label>Controls</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  see below

        Exclusion Criteria:

          -  Diabetes mellitus, acute infections
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lesley V Campbell, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Garvan Institute of Medical Research</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lisa Sze, MD</last_name>
    <phone>++61 2 9295 8214</phone>
    <email>l.sze@garvan.org.au</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alex Viardot, MD</last_name>
    <phone>++61 2 9295 8310</phone>
    <email>a.viardot@garvan.org.au</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Garvan Institute of Medical Research</name>
      <address>
        <city>Darlinghurst Sydney</city>
        <state>New South Wales</state>
        <zip>2010</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Australia</country>
  </location_countries>
  <verification_date>October 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 29, 2007</study_first_submitted>
  <study_first_submitted_qc>October 29, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 30, 2007</study_first_posted>
  <last_update_submitted>October 29, 2007</last_update_submitted>
  <last_update_submitted_qc>October 29, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 30, 2007</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Prader-Willi Syndrome</mesh_term>
    <mesh_term>Hyperphagia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Exenatide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

